María Yllescas

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Jesús Rodríguez‐Baño, Jerónimo Pachón, Jordi Carratalà et al. · Clinical Microbiology and Infection · 2020 · 127 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score

Juan Berenguer, Alberto M Borobia, Pablo Ryan et al. · Thorax · 2021 · 96 citations · Full text

Medicine, Emergency Medicine, Internal Medicine +17

Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients

Elena Sendagorta, José Ignacio Bernardino, Mario Álvarez Gallego et al. · AIDS · 2015 · 23 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17